John H. Joseph MD

Appearances

Safety and Duration of Effect of 40-Unit PrabotulinumtoxinA-xvfs for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients: A Phase II, Multicenter, Randomized, Double-Blind, Active-Controlled Trial
Date
November 22, 2024
Background: Extending the duration of effect of botulinum toxins—by administering doses beyond those of the approved labels—has been an area of increasing interest in the field of aesthetics…
Speakers
Steve Fagien, MD
Rui L. Avelar, MD
Sue E. Cox, MD
John H. Joseph, MD
Joely Kaufman-Janette, MD
Keith A. Marcus, MD
A Multicenter, Randomized, Evaluator-Blinded Study to Examine the Safety and Effectiveness of Hyaluronic Acid Filler in the Correction of Infraorbital Hollows
Date
November 22, 2024
Background: Hyaluronic acid injections are increasingly administered for correction of infraorbital hollows (IOHs)…
Speakers
Brian Biesman, MD
John H. Joseph, MD
Jeremy B. Green, MD
Rosalyn George, MD
Carolyn Jacob, MD
Melanie Palm, MD
Derek H. Jones, MD
Lisa Grunebaum, MD
Kenneth Beer, MD
Young Cho, MD, PhD
Birgitta Almegard, PhD
Felipe Weinberg, MD
Torun Bromee, PhD